Human papillomavirus detection, genotyping and integration in uterine cervical neoplasia patients.

Human papillomavirus detection, genotyping and integration in uterine cervical neoplasia patients. - HPV integration in cervical neoplasia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012402

Enrollment

300

Registered

2013-11-25

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine cervical intraepithelial neoplasia, and cervical cancer

Interventions

punch biopsy from uterine cervix

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The women who has diagnosed with cervical intraepithelial neoplasia or cervical cancer.

Exclusion criteria

Exclusion criteria: not available

Design outcomes

Primary

Measure	Time frame
The evaluation of integration rate of HPV in uterine cervical neoplasia.	—

Countries

Japan

Contacts

Public ContactYoshito Terai

Osaka Medical College Obstetrics and Gynecology

y-terai@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026